Immunogenicity and safety of an AS03-adjuvanted H7N1 vaccine in adults 65years of age and older: A phase II, observer-blind, randomized, controlled trial.
Vaccine
; 35(15): 1865-1872, 2017 04 04.
Article
in En
| MEDLINE
| ID: mdl-28302407
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Polysorbates
/
Squalene
/
Influenza Vaccines
/
Alpha-Tocopherol
/
Influenza A Virus, H7N1 Subtype
/
Antibodies, Viral
Type of study:
Clinical_trials
/
Guideline
Language:
En
Journal:
Vaccine
Year:
2017
Type:
Article